We serve Chemical Name:1,1-diethoxybut-2-ene CAS:10602-34-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,1-diethoxybut-2-ene
CAS.NO:10602-34-3
Synonyms:1,1-Diethoxy-2-butene;2-Butenal diethyl acetal;Crotonaldehyd-diethylacetal;crotonaldehyde diethylacetal;EINECS 234-224-7;Crotonaldehyde acetal;Crotonaldehyd-diaethylacetal;1,1-diethoxy-but-2-ene;2-Butene,1,1-diethoxy;diethyl acetal of crotonaldehyde
Molecular Formula:C8H16O2
Molecular Weight:144.21100
HS Code:2911000000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:147.5ºC at 760mmHg
Density:0.861g/cm3
Index of Refraction:1.423
PSA:18.46000
Exact Mass:144.11500
LogP:1.96160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,1-Diethoxy-2-butene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,diethyl acetal of crotonaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,diethyl acetal of crotonaldehyde Use and application,crotonaldehyde diethylacetal technical grade,usp/ep/jp grade.
Related News: Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma. 1,1-diethoxybut-2-ene manufacturer The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. 1,1-diethoxybut-2-ene supplier Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 1,1-diethoxybut-2-ene vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 1,1-diethoxybut-2-ene factory We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.
